Europe's 'FDA' in limbo as hidden costs of Brexit continue to mount

London

WHEN it switched offices in London not long ago, the European Medicines Agency (EMA) signed a 25-year lease on a shiny new building in the east of the city.

Just two years later, the organisation is preparing to relocate again, but this time its likely move has sent tremors through Britain's pharmaceutical industry and raised fears over public safety.